查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1908629

全球伴侣动物药品市场：市场规模、份额和趋势分析（按产品、动物、适应症、分销管道和地区划分），细分市场预测（2026-2034 年）

Companion Animal Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals, Medicated Feed Additives), By Animal, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2034
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

伴侣动物医药市场概览

全球伴侣动物药品市场预计到 2025 年将价值 258.8 亿美元，预计到 2034 年将达到 669.6 亿美元。

预计从 2026 年到 2034 年，该市场将以 11.22% 的复合年增长率成长。成长要素包括伴侣动物药物的快速发展、宠物人性化程度的提高和宠物相关支出的增加、支持性政策以及全球宠物数量动态的变化。

动物医药的进步正推动着针对各种动物疾病和健康状况开发出更有效、更有针对性的治疗方法。新药和疗法疗效更高、副作用更少、动物预后更好，从而推动了对创新动物医药的需求。

产品核可的增加、对精准医疗的日益重视、宠物保险的日益普及、兽医医疗成本的上涨、再生医学技术的兴起以及对先进动物护理需求的不断增长，预计将在不久的将来推动动物医药的进步。例如，根据2025年2月25日发表在dvm360上的一篇报导，美国食品药物管理局（FDA）可能在2025年3月之前有条件地核准雷帕霉素上市。雷帕霉素是一种标靶治疗，目前正在进行临床试验，检验其逆转猫肥厚型心肌病（HCM）的有效性。

同样，2025年3月和4月，美国食品药物管理局（FDA）核准了两种用于猫和观赏鱼的新型兽药。 2025年3月， 美国有条件核准了Felycin-CA1（Sirolimus缓释片），这是首个核准治疗猫无症状性肥厚型心肌病（HCM）的药物。该产品由爱尔兰Trivium Vet公司生产，旨在控制猫的心室肥厚，且不会抑制免疫系统。

这些进展凸显了宠物治疗方案正朝着更精准、更有效率、安全的方向发展。随着兽医学的进步，标靶治疗和新型药物输送系统的研发将有助于疾病管理，并改善动物的整体健康状况。宠物健康意识的提高、兽医护理成本的上涨以及宠物保险的普及，都推动了对创新的日益重视，进而促进了对先进兽医解决方案的需求。预计这些因素将推动该行业的成长，并重塑伴侣动物医学的未来。

目录

第一章 分析方法和范围

第二章执行摘要

3. 伴侣动物药品市场：驱动因素、趋势与范围

  • 市场关联性展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场分析工具
    • 波特五力分析
    • PESTEL分析（基于SWOT分析）
  • 定价分析：按产品划分
  • 产品平臺分析
  • 主要品种疾病流行情形分析（2024 年）

第四章 全球伴侣动物药品市场：依产品分類的估算与趋势分析

  • 全球伴侣动物药品市场：按产品分類的趋势分析（2025 年和 2034 年）
  • 生技药品
    • 疫苗
    • 其他生技药品
  • 製药
    • 驱虫药
    • 抗感染药物
    • 止痛药
    • 抗发炎药
    • 其他药物
  • 药用饲料添加剂

第五章 全球伴侣动物药品市场：按物种分類的估算与趋势分析

  • 全球伴侣动物药品市场：按物种分類的趋势分析（2025 年和 2034 年）
  • 狗
  • 猫
  • 马
  • 其他动物

第六章：全球伴侣动物药品市场：依适应症分類的估算与趋势分析

  • 全球伴侣动物药品市场：按适应症分類的趋势分析（2025 年和 2034 年）
  • 感染疾病
  • 皮肤病
  • 疼痛
  • 整形外科疾病
  • 行为障碍
  • 其他迹象

第七章 全球伴侣动物药品市场：按通路分類的估算与趋势分析

  • 全球伴侣动物药品市场：按分销管道分類的趋势分析（2025 年和 2034 年）
  • 零售
  • 电子商务
  • 医院/诊所药房

第八章：全球伴侣动物药品市场：区域估算与趋势分析

  • 按地区分類的市场份额（2025 年和 2034 年）
  • 市场概览：按地区
  • 市场概览：按地区划分
  • 市场规模预测及趋势分析（2021-2034）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 市场参与企业分类
  • 企业市场分析/热力图分析（2025 年）
  • 公司简介
    • Merck &Co., Inc.
    • Ceva
    • Vetoquinol
    • Zoetis
    • Boehringer Ingelheim International GmbH
    • Elanco Animal Health Incorporated
    • Ourofino Animal Health
    • Virbac
    • Phibro Animal Health Corporation
    • Dechra Pharmaceuticals Plc
    • Bimeda Inc.
  • 其他主要企业名单
Product Code: GVR-4-68039-698-0

Companion Animal Medicine Market Summary

The global companion animal medicine market size was estimated at USD 25.88 billion in 2025 and is projected to reach USD 66.96 billion by 2034, growing at a CAGR of 11.22% from 2026 to 2034. The market is primarily driven by factors like rapid advancements in companion animal medicine, increasing humanization of pets & expenditure on pets, supportive initiatives, and changing pet demographics globally.

Advancements in veterinary medicines have led to the development of more effective and targeted treatments for various animal diseases and health conditions. New drugs and therapies offer improved efficacy, reduced adverse effects, and better animal outcomes, driving demand for innovative veterinary medications.

Increasing product approvals, rising focus on precision medicine, increasing uptake of pet insurance, growing animal health expenditure, the emergence of regenerative medicine techniques, and increasing demand for advanced animal care are expected to drive advancements in veterinary medicine in the near future. For instance, according to a dvm360 article from February 25, 2025, the FDA might provide conditional approval by March 2025 for a targeted drug known as rapamycin, which is currently under clinical trials for testing its efficacy in reversing hypertrophic cardiomyopathy (HCM) in felines.

Similarly, in March and April 2025, the US FDA approved two new veterinary drugs for cats and ornamental pet fish. In March 2025, the U.S. (FDA) granted conditional approval for Felycin-CA1 (sirolimus delayed-release tablets), the first approved treatment for cats suffering from subclinical hypertrophic cardiomyopathy (HCM). The product, manufactured by TriviumVet, an Ireland-based company, aims to manage cat ventricular hypertrophy without suppressing the immune system.

Such advancements highlight a shift toward more precise, effective, and safer pet treatment options. As veterinary science evolves, developing targeted therapies and novel drug delivery systems will enhance disease management and overall animal well-being. This growing focus on innovation, supported by increasing pet health awareness, rising veterinary care expenditures, and broader adoption of pet insurance, is driving demand for advanced veterinary solutions. These factors are expected to accelerate the sector's growth and reshape the future of companion animal medicine.

Global Companion Animal Medicine Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2034. For the purpose of this report, Grand View Research has segmented the global companion animal medicine market report on the basis of product, application, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2034)
  • Biologics
    • Vaccines
    • Modified/ Attenuated Live
    • Inactivated (Killed)
    • Other Vaccines
    • Other Biologics
    • Monoclonal Antibody (mAb)
    • Dogs
    • Cats
    • Other Biologics (excluding mAb)
  • Pharmaceuticals
    • Parasiticides
    • Anti-infectives
    • Anti-inflammatory
    • Analgesics
    • Other Pharmaceuticals
  • Medicated Feed Additives
  • Animal Outlook (Revenue, USD Million, 2021 - 2034)
  • Dogs
  • Cats
  • Horses
  • Other Animals
  • Indication Outlook (Revenue, USD Million, 2021 - 2034)
  • Infectious Diseases
  • Dermatologic Diseases
  • Pain
  • Orthopedic Diseases
  • Behavioral Diseases
  • Other Indications
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2034)
  • Retail
  • E-commerce
  • Hospitals/Clinics
  • Regional Outlook (Revenue, USD Million, 2021 - 2034)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definition
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
  • 1.6. Market Formulation & Visualization
  • 1.7. Data Validation & Publishing
  • 1.8. Model Details
    • 1.8.1. Model Analysis 1
    • 1.8.2. Model Analysis 2
    • 1.8.3. Model Analysis 3
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Companion Animal Medicine Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rapid Advancements in the Field of Companion Animal Medicine
      • 3.2.1.2. Increasing Humanization of Pets & Expenditure on Pets
      • 3.2.1.3. Support Initiatives
      • 3.2.1.4. Changing Pet Demographics Globally
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Emergence of Adverse Drug Reactions (ADR)
      • 3.2.2.2. Complex Regulations
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis, by SWOT
  • 3.4. Pricing Analysis, by Product
  • 3.5. Product Pipeline Analysis
  • 3.6. Estimated Disease Prevalence Analysis by Key Species, 2024

Chapter 4. Global Companion Animal Medicine Market: By Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Companion Animal Medicine Market: By Product Movement Analysis, 2025 & 2034 (USD Million)
  • 4.3. Biologics
    • 4.3.1. Biologics Market Estimates And Forecasts, 2021 - 2034 (USD Million)
    • 4.3.2. Vaccines
      • 4.3.2.1. Vaccines Market Estimates And Forecasts, 2021 - 2034 (USD Million)
      • 4.3.2.2. Modified/ Attenuated Live
        • 4.3.2.2.1. Modified/ Attenuated Live Market Estimates And Forecasts, 2021 - 2034 (USD Million)
      • 4.3.2.3. Inactivated (Killed)
        • 4.3.2.3.1. Inactivated (Killed) Market Estimates And Forecasts, 2021 - 2034 (USD Million)
      • 4.3.2.4. Other Vaccines
        • 4.3.2.4.1. Other Vaccines Market Estimates And Forecasts, 2021 - 2034 (USD Million)
    • 4.3.3. Other Biologics
      • 4.3.3.1. Other Biologics Market Estimates And Forecasts, 2021 - 2034 (USD Million)
      • 4.3.3.2. Monoclonal Antibody (mAb)
        • 4.3.3.2.1. Monoclonal Antibody (mAb) Market Estimates And Forecasts, 2021 - 2034 (USD Million)
        • 4.3.3.2.2. Dogs
          • 4.3.3.2.2.1. Dogs Market Estimates And Forecasts, 2021 - 2034 (USD Million)
        • 4.3.3.2.3. Cats
          • 4.3.3.2.3.1. Cats Market Estimates And Forecasts, 2021 - 2034 (USD Million)
      • 4.3.3.3. Other Biologics (excluding mAb)
        • 4.3.3.3.1. Other Biologics (excluding mAb) Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 4.4. Pharmaceuticals
    • 4.4.1. Pharmaceuticals Market Estimates And Forecasts, 2021 - 2034 (USD Million)
    • 4.4.2. Parasiticides
      • 4.4.2.1. Parasiticides Market Estimates And Forecasts, 2021 - 2034 (USD Million)
    • 4.4.3. Anti-infectives
      • 4.4.3.1. Anti-infectives Market Estimates And Forecasts, 2021 - 2034 (USD Million)
    • 4.4.4. Analgesics
      • 4.4.4.1. Analgesics Market Estimates And Forecasts, 2021 - 2034 (USD Million)
    • 4.4.5. Anti-inflammatory
      • 4.4.5.1. Anti-inflammatory Market Estimates And Forecasts, 2021 - 2034 (USD Million)
    • 4.4.6. Other Pharmaceuticals
      • 4.4.6.1. Other Pharmaceuticals Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 4.5. Medicated Feed Additives
    • 4.5.1. Medicated Feed Additives Market Estimates And Forecasts, 2021 - 2034 (USD Million)

Chapter 5. Global Companion Animal Medicine Market: By Animal Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Companion Animal Medicine Market: By Animal Movement Analysis, 2025 & 2034 (USD Million)
  • 5.3. Dogs
    • 5.3.1. Dogs Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 5.4. Cats
    • 5.4.1. Cats Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 5.5. Horses
    • 5.5.1. Horses Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 5.6. Other Animals
    • 5.6.1. Other Animals Market Estimates And Forecasts, 2021 - 2034 (USD Million)

Chapter 6. Global Companion Animal Medicine Market: By Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Companion Animal Medicine Market: By Indication Movement Analysis, 2025 & 2034 (USD Million)
  • 6.3. Infectious Diseases
    • 6.3.1. Infectious Diseases Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 6.4. Dermatologic Diseases
    • 6.4.1. Dermatologic Diseases Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 6.5. Pain
    • 6.5.1. Pain Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 6.6. Orthopedic Diseases
    • 6.6.1. Orthopedic Diseases Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 6.7. Behavioral Diseases
    • 6.7.1. Behavioral Diseases Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 6.8. Other Indications
    • 6.8.1. Other Indications Market Estimates And Forecasts, 2021 - 2034 (USD Million)

Chapter 7. Global Companion Animal Medicine Market: By Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Companion Animal Medicine Market: By Distribution Channel Movement Analysis, 2025 & 2034 (USD Million)
  • 7.3. Retail
    • 7.3.1. Retail Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 7.4. E-commerce
    • 7.4.1. E-commerce Market Estimates And Forecasts, 2021 - 2034 (USD Million)
  • 7.5. Hospital/ Clinic Pharmacy
    • 7.5.1. Hospital/ Clinic Pharmacy Market Estimates And Forecasts, 2021 - 2034 (USD Million)

Chapter 8. Global Companion Animal Medicine Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2034
  • 8.2. Regional Market Dashboard
  • 8.3. Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2021 to 2034:
  • 8.5. North America
    • 8.5.1. North America market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.5.2. U.S.
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. U.S. market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Canada market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Mexico market estimates and forecasts 2021 to 2034 (USD Million)
  • 8.6. Europe
    • 8.6.1. Europe market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.6.2. UK
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. UK market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.6.3. Germany
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Germany market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.6.4. France
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. France market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.6.5. Italy
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Italy market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.6.6. Spain
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Spain market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.6.7. Norway
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Norway market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.6.8. Sweden
      • 8.6.8.1. Key Country Dynamics
      • 8.6.8.2. Competitive Scenario
      • 8.6.8.3. Regulatory Framework
      • 8.6.8.4. Sweden market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.6.9. Denmark
      • 8.6.9.1. Key Country Dynamics
      • 8.6.9.2. Competitive Scenario
      • 8.6.9.3. Regulatory Framework
      • 8.6.9.4. Denmark market estimates and forecasts 2021 to 2034 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Asia Pacific market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.7.2. Japan
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Japan market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.7.3. China
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. China market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.7.4. India
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. India market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.7.5. Australia
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Australia market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.7.6. South Korea
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. South Korea market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.7.7. Thailand
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Thailand market estimates and forecasts 2021 to 2034 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Latin America market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.8.2. Brazil
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Brazil market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Argentina market estimates and forecasts 2021 to 2034 (USD Million)
  • 8.9. MEA
    • 8.9.1. MEA market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.9.2. South Africa
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Competitive Scenario
      • 8.9.2.3. Regulatory Framework
      • 8.9.2.4. South Africa market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.9.3. Saudi Arabia
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Competitive Scenario
      • 8.9.3.3. Regulatory Framework
      • 8.9.3.4. Saudi Arabia market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.9.4. UAE
      • 8.9.4.1. Key Country Dynamics
      • 8.9.4.2. Competitive Scenario
      • 8.9.4.3. Regulatory Framework
      • 8.9.4.4. UAE market estimates and forecasts 2021 to 2034 (USD Million)
    • 8.9.5. Kuwait
      • 8.9.5.1. Key Country Dynamics
      • 8.9.5.2. Competitive Scenario
      • 8.9.5.3. Regulatory Framework
      • 8.9.5.4. Kuwait market estimates and forecasts 2021 to 2034 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Participant Categorization
  • 9.2. Company Market Position Analysis/ Heat Map Analysis, 2025
  • 9.3. Company Profile
    • 9.3.1. Merck & Co., Inc.
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Product benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. Ceva
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Vetoquinol
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Zoetis
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Boehringer Ingelheim International GmbH
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Elanco Animal Health Incorporated
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Ourofino Animal Health
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Virbac
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Phibro Animal Health Corporation
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Dechra Pharmaceuticals Plc
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Bimeda Inc.
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
  • 9.4. List of other Key players

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 4. Global Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 5. Global Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 6. Global Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 7. Global Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 8. Global Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 9. Global Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 10. Global Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 11. Global Companion Animal Medicine Market, by Region, 2021 - 2034 (USD Million)
  • Table 12. North America Companion Animal Medicine Market, by Country, 2021 - 2034 (USD Million)
  • Table 13. North America Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 14. North America Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 15. North America Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 16. North America Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 17. North America Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 18. North America Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 19. North America Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 20. North America Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 21. U.S. Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 22. U.S. Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 23. U.S. Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 24. U.S. Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 25. Canada Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 26. Canada Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 27. Canada Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 28. Canada Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 29. Canada Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 30. Canada Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 31. Canada Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 32. Canada Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 33. Mexico Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 34. Mexico Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 35. Mexico Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 36. Mexico Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 37. Mexico Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 38. Mexico Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 39. Mexico Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 40. Mexico Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 41. Europe Companion Animal Medicine Market, by Country, 2021 - 2034 (USD Million)
  • Table 42. Europe Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 43. Europe Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 44. Europe Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 45. Europe Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 46. Europe Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 47. Europe Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 48. Europe Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 49. Europe Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 50. Germany Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 51. Germany Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 52. Germany Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 53. Germany Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 54. Germany Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 55. Germany Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 56. Germany Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 57. Germany Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 58. UK Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 59. UK Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 60. UK Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 61. UK Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 62. UK Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 63. UK Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 64. UK Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 65. UK Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 66. France Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 67. France Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 68. France Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 69. France Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 70. France Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 71. France Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 72. France Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 73. France Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 74. Italy Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 75. Italy Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 76. Italy Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 77. Italy Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 78. Italy Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 79. Italy Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 80. Italy Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 81. Italy Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 82. Spain Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 83. Spain Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 84. Spain Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 85. Spain Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 86. Spain Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 87. Spain Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 88. Spain Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 89. Spain Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 90. Denmark Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 91. Denmark Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 92. Denmark Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 93. Denmark Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 94. Denmark Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 95. Denmark Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 96. Denmark Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 97. Denmark Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 98. Sweden Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 99. Sweden Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 100. Sweden Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 101. Sweden Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 102. Sweden Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 103. Sweden Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 104. Sweden Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 105. Sweden Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 106. Norway Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 107. Norway Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 108. Norway Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 109. Norway Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 110. Norway Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 111. Norway Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 112. Norway Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 113. Norway Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 114. Asia Pacific Companion Animal Medicine Market, by Country, 2021 - 2034 (USD Million)
  • Table 115. Asia Pacific Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 116. Asia Pacific Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 117. Asia Pacific Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 118. Asia Pacific Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 119. Asia Pacific Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 120. Asia Pacific Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 121. Asia Pacific Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 122. Asia Pacific Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 123. China Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 124. China Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 125. China Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 126. China Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 127. China Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 128. China Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 129. China Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 130. China Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 131. Japan Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 132. Japan Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 133. Japan Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 134. Japan Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 135. Japan Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 136. Japan Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 137. Japan Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 138. Japan Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 139. India Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 140. India Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 141. India Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 142. India Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 143. India Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 144. India Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 145. India Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 146. India Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 147. South Korea Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 148. South Korea Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 149. South Korea Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 150. South Korea Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 151. South Korea Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 152. South Korea Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 153. South Korea Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 154. South Korea Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 155. Australia Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 156. Australia Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 157. Australia Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 158. Australia Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 159. Australia Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 160. Australia Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 161. Australia Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 162. Australia Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 163. Thailand Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 164. Thailand Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 165. Thailand Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 166. Thailand Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 167. Thailand Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 168. Thailand Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 169. Thailand Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 170. Thailand Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 171. Latin America Companion Animal Medicine Market, by Country, 2021 - 2034 (USD Million)
  • Table 172. Latin America Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 173. Latin America Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 174. Latin America Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 175. Latin America Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 176. Latin America Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 177. Latin America Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 178. Latin America Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 179. Latin America Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 180. Brazil Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 181. Brazil Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 182. Brazil Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 183. Brazil Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 184. Brazil Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 185. Brazil Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 186. Brazil Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 187. Brazil Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 188. Argentina Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 189. Argentina Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 190. Argentina Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 191. Argentina Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 192. Argentina Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 193. Argentina Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 194. Argentina Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 195. Argentina Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 196. Middle East & Africa Companion Animal Medicine Market, by Country, 2021 - 2034 (USD Million)
  • Table 197. Middle East & Africa Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 198. Middle East & Africa Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 199. Middle East & Africa Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 200. Middle East & Africa Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 201. Middle East & Africa Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 202. Middle East & Africa Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 203. Middle East & Africa Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 204. Middle East & Africa Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 205. South Africa Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 206. South Africa Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 207. South Africa Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 208. South Africa Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 209. South Africa Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 210. South Africa Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 211. South Africa Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 212. South Africa Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 213. Saudi Arabia Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 214. Saudi Arabia Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 215. Saudi Arabia Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 216. Saudi Arabia Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 217. Saudi Arabia Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 218. Saudi Arabia Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 219. Saudi Arabia Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 220. Saudi Arabia Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 221. UAE Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 222. UAE Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 223. UAE Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 224. UAE Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 225. UAE Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 226. UAE Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 227. UAE Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 228. UAE Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 229. Kuwait Companion Animal Medicine Market, By Product, 2021 - 2034 (USD Million)
  • Table 230. Kuwait Companion Animal Medicine Market, Vaccines, 2021 - 2034 (USD Million)
  • Table 231. Kuwait Companion Animal Medicine Market, Other Biologics, 2021 - 2034 (USD Million)
  • Table 232. Kuwait Companion Animal Medicine Market, Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Table 233. Kuwait Companion Animal Medicine Market, Pharmaceuticals, 2021 - 2034 (USD Million)
  • Table 234. Kuwait Companion Animal Medicine Market, By Animal, 2021 - 2034 (USD Million)
  • Table 235. Kuwait Companion Animal Medicine Market, By Indication, 2021 - 2034 (USD Million)
  • Table 236. Kuwait Companion Animal Medicine Market, By Distribution Channel, 2021 - 2034 (USD Million)
  • Table 237. Company Overview
  • Table 238. Product Benchmarking
  • Table 239. Financial Performance
  • Table 240. Strategic Initiatives

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Companion Animal Medicine Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 PESTEL Analysis, by SWOT
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 Global Companion Animal Medicine Market, for Product, 2021 - 2034 (USD Million)
  • Fig. 16 Global Companion Animal Medicine Market, for Biologics, 2021 - 2034 (USD Million)
  • Fig. 17 Global Companion Animal Medicine Market, for Vaccines, 2021 - 2034 (USD Million)
  • Fig. 18 Global Companion Animal Medicine Market, for Modified/ Attenuated Live, 2021 - 2034 (USD Million)
  • Fig. 19 Global Companion Animal Medicine Market, for Inactivated (Killed), 2021 - 2034 (USD Million)
  • Fig. 20 Global Companion Animal Medicine Market, for Other Vaccines, 2021 - 2034 (USD Million)
  • Fig. 21 Global Companion Animal Medicine Market, for Other Biologics, 2021 - 2034 (USD Million)
  • Fig. 22 Global Companion Animal Medicine Market, for Monoclonal Antibody (mAb), 2021 - 2034 (USD Million)
  • Fig. 23 Global Companion Animal Medicine Market, for Dogs, 2021 - 2034 (USD Million)
  • Fig. 24 Global Companion Animal Medicine Market, for Cats, 2021 - 2034 (USD Million)
  • Fig. 25 Global Companion Animal Medicine Market, for Other Biologics (excluding mAb), 2021 - 2034 (USD Million)
  • Fig. 26 Global Companion Animal Medicine Market, for Pharmaceuticals, 2021 - 2034 (USD Million)
  • Fig. 27 Global Companion Animal Medicine Market, for Parasiticides, 2021 - 2034 (USD Million)
  • Fig. 28 Global Companion Animal Medicine Market, for Anti-infectives, 2021 - 2034 (USD Million)
  • Fig. 29 Global Companion Animal Medicine Market, for Anti-inflammatory, 2021 - 2034 (USD Million)
  • Fig. 30 Global Companion Animal Medicine Market, for Analgesics, 2021 - 2034 (USD Million)
  • Fig. 31 Global Companion Animal Medicine Market, for Other Pharmaceuticals, 2021 - 2034 (USD Million)
  • Fig. 32 Global Companion Animal Medicine Market, for Medicated Feed Additives, 2021 - 2034 (USD Million)
  • Fig. 33 Global Companion Animal Medicine Market, for Animal, 2021 - 2034 (USD Million)
  • Fig. 34 Global Companion Animal Medicine Market, for Dogs, 2021 - 2034 (USD Million)
  • Fig. 35 Global Companion Animal Medicine Market, for Cats 2021 - 2034 (USD Million)
  • Fig. 36 Global Companion Animal Medicine Market, for Horses 2021 - 2034 (USD Million)
  • Fig. 37 Global Companion Animal Medicine Market, for Other Animals 2021 - 2034 (USD Million)
  • Fig. 38 Global Companion Animal Medicine Market, for Indication 2021 - 2034 (USD Million)
  • Fig. 39 Global Companion Animal Medicine Market, for Infectious Diseases 2021 - 2034 (USD Million)
  • Fig. 40 Global Companion Animal Medicine Market, for Dermatologic Diseases 2021 - 2034 (USD Million)
  • Fig. 41 Global Companion Animal Medicine Market, for Pain 2021 - 2034 (USD Million)
  • Fig. 42 Global Companion Animal Medicine Market, for Orthopedic Diseases 2021 - 2034 (USD Million)
  • Fig. 43 Global Companion Animal Medicine Market, for Behavioral Diseases 2021 - 2034 (USD Million)
  • Fig. 44 Global Companion Animal Medicine Market, for Other Indications 2021 - 2034 (USD Million)
  • Fig. 45 Global Companion Animal Medicine Market, for Distribution Channel 2021 - 2034 (USD Million)
  • Fig. 46 Global Companion Animal Medicine Market, for Retail 2021 - 2034 (USD Million)
  • Fig. 47 Global Companion Animal Medicine Market, for E-commerce 2021 - 2034 (USD Million)
  • Fig. 48 Global Companion Animal Medicine Market, for Hospitals/Clinics 2021 - 2034 (USD Million)
  • Fig. 49 Regional Outlook, 2025 & 2034
  • Fig. 50 North America Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 51 U.S. Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 52 Canada Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 53 Mexico Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 54 Europe Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 55 Germany Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 56 UK Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 57 France Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 58 Italy Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 59 Spain Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 60 Denmark Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 61 Sweden Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 62 Norway Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 63 Asia Pacific Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 64 Japan Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 65 China Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 66 India Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 67 Australia Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 68 South Korea Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 69 Thailand Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 70 Latin America Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 71 Brazil Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 72 Argentina Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 73 Middle East and Africa Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 74 South Africa Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 75 Saudi Arabia Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 76 UAE Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 77 Kuwait Companion Animal Medicine Market, 2021 - 2034 (USD Million)
  • Fig. 78 Heat map analysis